G
Giampietro Gasparini
Researcher at Catholic University of the Sacred Heart
Publications - 204
Citations - 14201
Giampietro Gasparini is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 49, co-authored 202 publications receiving 13718 citations.
Papers
More filters
Journal ArticleDOI
Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
Noel Weidner,Judah Folkman,F. Pozza,P. Bevilacqua,Elizabeth N. Allred,Dan H. Moore,S. Meli,Giampietro Gasparini +7 more
TL;DR: Microvessel density in the area of the most intense neovascularization in invasive breast carcinoma is an independent and highly significant prognostic indicator for overall and relapse-free survival in patients with early-stage breast carcinom (I or II by International Union Against Cancer criteria).
Journal ArticleDOI
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The multicenter Italian lung cancer in the elderly study (MILES) phase III randomized trial
Cesare Gridelli,Francesco Perrone,Ciro Gallo,S. Cigolari,Antonio Rossi,Francovito Piantedosi,Santi Barbera,F. Ferraù,E. Piazza,Francesco Rosetti,M. Clerici,Oscar Bertetto,Sergio Federico Robbiati,Luciano Frontini,Cosimo Sacco,Federico Castiglione,Adolfo Favaretto,Silvia Novello,Maria Rita Migliorino,Giampietro Gasparini,Domenico Galetta,Rosario Vincenzo Iaffaioli,Vittorio Gebbia +22 more
TL;DR: Although quality of life was similar across the three treatment arms, the combination treatment was more toxic than the two drugs given singly and not more effective than single-agent vinorelbine or gemcitabine in the treatment of elderly patients with advanced NSCLC.
Journal ArticleDOI
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation
P. E. Vermeulen,Giampietro Gasparini,Stephen B. Fox,Masakazu Toi,L. Martin,Peter McCulloch,Francesco Pezzella,Giuseppe Viale,Noel Weidner,Adrian L. Harris,Luc Dirix +10 more
TL;DR: ‘Angiogenesis Group, Department of Oncology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium'; ‘ICRF Molecular Oncologists, University of Oxford, Oxford, U.K.
Journal ArticleDOI
Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
Giampietro Gasparini,Masakazu Toi,Massimo Gion,Paolo Verderio,Ruggero Dittadi,Hanatani Mitsuya,Matsubara Isamu,Orazio Vinante,Emanuela Bonoldi,Patrizia Boracchi,C. Gatti,Hideo Suzuki,Takeshi Tominaga +12 more
TL;DR: Levels of VEGF in tumor tissue samples are found to be prognostic for both relapse-free and overall survival in univariate and multivariate analyses, and all four P values < .001 were found.
Journal ArticleDOI
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli,Gualberto Gussoni,Carlo Bianchini,Melina Verso,Mario Mandalà,Luigi Cavanna,Sandro Barni,Roberto Labianca,Franco Buzzi,Giovanni Scambia,Rodolfo Passalacqua,Sergio Ricci,Giampietro Gasparini,Vito Lorusso,Erminio Bonizzoni,Maurizio Tonato +15 more
TL;DR: Nadroparin reduces the incidence of thromboembolic events in ambulatory patients with metastatic or locally advanced cancer who are receiving chemotherapy, and future studies should focus on patients who are at a high risk for thrombolic events.